title: Electrochemical assay of heparin to monitor anticoagulation action in cardiovascular patients.
abstract: Complications in anticoagulation therapy and long term consequences of the post thrombotic syndromes requires a fast and powerful therapy such as heparin therapy (anticoagulation) to minimize the thrombotic effects in patients. Thus, a simple approach via electrochemical method: Differential pulse polarography (DPP) has been developed for heparin analysis as a powerful clinical tool to monitor anticoagulation action in-patient undergoing heparin therapy. The method has been standardized for determination of heparin activity over the existing methods and a very well defined characteristic reduction peak at -1.25 V in 2 M NaOH was observed for heparin. A linear relation was observed with a regression equation as y = 0.3117x + 0.8069, for 0.1 to 2.0 units/ml heparin. The developed DPP method was observed with excellent precision, accuracy and recovery in human blood plasma samples and in pharmacological formulations. The limit of detection (LOD) and limit of quantification (LOQ) noticed to be 2.04 and 6.8 units/ml respectively. The DPP results compared with pharmacological screening through average thrombin time (TT) and applied to monitor invitro anticoagulation action of heparin in healthy human subjects. Statistical analysis done to validate developed DPP method for heparin analysis and its probable clinical use to monitor anticoagulation action to treat patients suffering from various cerebrovascular disorders (CVD) by proper dosing of heparin.
authors.affiliation: Department of Chemistry, Electrochemical Laboratory, Dr. Hari Singh Gour University, Sagar, MP 470003 India ; Nayan Studio, C/o Mr. Vivek Singh, Main Market, Khurai, Sagar, MP 470117 India.
authors.forename: Niyati
authors.initials: N
authors.lastname: Singh
keywords: Anticoagulation action; Average TT; Blood Transfusion Medicine; CVD; Citrated blood plasma; DPP; Hematology; Heparin; Human Genetics; Medicine & Public Health; Oncology